Your browser doesn't support javascript.
loading
Long COVID and cardiovascular disease: a prospective cohort study.
Lawson, Claire Alexandra; Moss, Alastair James; Arnold, Jayanth Ranjit; Bagot, Catherine; Banerjee, Amitava; Berry, Colin; Greenwood, John; Hughes, Alun D; Khunti, Kamlesh; Mills, Nicholas L; Neubauer, Stefan; Raman, Betty; Sattar, Naveed; Leavy, Olivia C; Richardson, Matthew; Elneima, Omer; McAuley, Hamish Jc; Shikotra, Aarti; Singapuri, Amisha; Sereno, Marco; Saunders, Ruth; Harris, Victoria; Houchen-Wolloff, Linzy; Greening, Neil J; Harrison, Ewen; Docherty, Annemarie B; Lone, Nazir I; Quint, Jennifer Kathleen; Chalmers, James; Ho, Ling-Pei; Horsley, Alex; Marks, Michael; Poinasamy, Krisnah; Evans, Rachael; Wain, Louise V; Brightling, Chris; McCann, Gerry P.
  • Lawson CA; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
  • Moss AJ; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
  • Arnold JR; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
  • Bagot C; Department of Haemostasis and Thrombosis, Glasgow Royal Infirmary, Glasgow, Glasgow, UK.
  • Banerjee A; Farr Institute of Health Informatics Research, University College London, London, UK.
  • Berry C; BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
  • Greenwood J; Cardiology, Golden Jubilee National Hospital, Clydebank, UK.
  • Hughes AD; Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Khunti K; Biomedical Imaging Sciences, University of Leeds, Leeds, UK.
  • Mills NL; MRC Unit for Lifelong Health and Ageing, University College London, London, UK.
  • Neubauer S; Leicester Real World Evidence Unit, Leicester Diabetes Centre, University of Leicester, Leicester, UK.
  • Raman B; BHF Centre for Cardiovascular Sciences, University of Edinburgh, Edinburgh, Edinburgh, UK.
  • Sattar N; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Leavy OC; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Richardson M; Institute of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
  • Elneima O; Department of Population Health Sciences, University of Leicester, Leicester, UK.
  • McAuley HJ; University of Leicester, Leicester, UK.
  • Shikotra A; University of Leicester, Leicester, UK.
  • Singapuri A; University of Leicester, Leicester, UK.
  • Sereno M; University of Leicester, Leicester, UK.
  • Saunders R; University of Leicester, Leicester, UK.
  • Harris V; University of Leicester, Leicester, UK.
  • Houchen-Wolloff L; University of Leicester, Leicester, UK.
  • Greening NJ; University of Leicester, Leicester, UK.
  • Harrison E; University of Leicester, Leicester, UK.
  • Docherty AB; University of Leicester, Leicester, UK.
  • Lone NI; University of Edinburgh, Edinburgh, UK.
  • Quint JK; University of Edinburgh, Edinburgh, UK.
  • Chalmers J; University of Edinburgh, Edinburgh, UK.
  • Ho LP; NHLI, Imperial College London, London, UK.
  • Horsley A; University of Dundee, Dundee, Dundee, UK.
  • Marks M; University of Oxford, Oxford, UK.
  • Poinasamy K; University of Manchester, Manchester, UK.
  • Evans R; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
  • Wain LV; Asthma and Lung UK, London, UK.
  • Brightling C; The Institute for Lung Health, University of Leicester, Leicester, UK.
  • McCann GP; Department of Population Health Sciences, University of Leicester, Leicester, UK.
Open Heart ; 11(1)2024 May 27.
Article en En | MEDLINE | ID: mdl-38802280
ABSTRACT

BACKGROUND:

Pre-existing cardiovascular disease (CVD) or cardiovascular risk factors have been associated with an increased risk of complications following hospitalisation with COVID-19, but their impact on the rate of recovery following discharge is not known.

OBJECTIVES:

To determine whether the rate of patient-perceived recovery following hospitalisation with COVID-19 was affected by the presence of CVD or cardiovascular risk factors.

METHODS:

In a multicentre prospective cohort study, patients were recruited following discharge from the hospital with COVID-19 undertaking two comprehensive assessments at 5 months and 12 months. Patients were stratified by the presence of either CVD or cardiovascular risk factors prior to hospitalisation with COVID-19 and compared with controls with neither. Full recovery was determined by the response to a patient-perceived evaluation of full recovery from COVID-19 in the context of physical, physiological and cognitive determinants of health.

RESULTS:

From a total population of 2545 patients (38.8% women), 472 (18.5%) and 1355 (53.2%) had CVD or cardiovascular risk factors, respectively. Compared with controls (n=718), patients with CVD and cardiovascular risk factors were older and more likely to have had severe COVID-19. Full recovery was significantly lower at 12 months in patients with CVD (adjusted OR (aOR) 0.62, 95% CI 0.43 to 0.89) and cardiovascular risk factors (aOR 0.66, 95% CI 0.50 to 0.86).

CONCLUSION:

Patients with CVD or cardiovascular risk factors had a delayed recovery at 12 months following hospitalisation with COVID-19. Targeted interventions to reduce the impact of COVID-19 in patients with cardiovascular disease remain an unmet need. TRAIL REGISTRATION NUMBER ISRCTN10980107.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / COVID-19 Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / COVID-19 Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article